Health Catalyst HCAT 深 沪
等待开盘 08-28 09:30:00 美东时间
1.59
0.000
0.00%
华盛通- 最 高1.645
- 今 开1.59
- 成交量 18.98万股
- 最 低 1.59
- 昨 收 1.59
- 总市值 1.20亿
- 52周最高 3.615
- 市盈率 静 --
- 换手率 0.25%
- 52周最低 0.9551
- 委 比 26.71%
- 总股本 7525.64万
- 历史最高 59.50
- 量 比 0.32
- 振 幅 3.46%
- 历史最低 0.9551
- 每 手 1
- 风险率 0.66%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 罗斯百货、迪尔股份获多家大行上调目标价；沃尔玛、Advance遭多家大行下调目标价
今日重点评级关注：摩根士丹利：维持Ultragenyx Pharmaceutical"超配"评级，目标价从67美元升至74美元；Truist Securities：维持Solid Biosciences"买入"评级，目标价从16美元升至20美元
08-24 16:40
This Teradyne Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Baird analyst Quinn Fredrickson downgraded Teradyne Inc (NASDAQ:TER) from Outperform to Neutral a...
08-21 23:08
Canaccord Genuity Downgrades Health Catalyst to Hold, Lowers Price Target to $1.8
Canaccord Genuity analyst Richard Close downgrades Health Catalyst (NASDAQ:HCAT) from Buy to Hold and lowers the price target from $3 to $1.8.
08-21 20:42
美股大行评级 | 潜在涨幅544.53%！Scynexis获古根海姆升目标价至33美元，维持"买入"评级
今日重点评级关注：古根海姆：维持Scynexis"买入"评级，目标价从24美元升至33美元；韦德布什：维持Kura Oncology"跑赢大市"评级，目标价从36美元升至38美元
08-14 11:51
Health Catalyst Shares Tumble Overnight: What Investors Need to Know
Health Catalyst Inc. (NASDAQ:HCAT) shares fell 24.68% in Thursday’s overnight session after the company forecast a sharp sequential revenue decline for the third quarter despite topping its own second-quarter guidance. The stock closed Thursday’s regular session down 3.35% at $2.31 before falling an...
08-07 14:26
Health Catalyst shares are trading lower after the company issued Q3 sales and FY2026 sales guidance below estimates.
Health Catalyst shares are trading lower after the company issued Q3 sales and FY2026 sales guidance below estimates.
08-07 05:11
Health Catalyst Sells VitalWare, Refocuses Core Operations
Health Catalyst ( ($HCAT) ) has issued an announcement. On July 31, 2026, Healt...
08-07 04:58
Health Catalyst Sees Q3 Sales $55.000M-$56.000M vs $62.159M Est
Health Catalyst (NASDAQ:HCAT) sees Q3 sales of $55.000 million-$56.000 million vs $62.159 million analyst estimate.
08-07 04:09
Health Catalyst Q2 Adj. EPS $0.04 Beats $0.03 Estimate, Sales $70.487M Beat $69.059M Estimate
Health Catalyst (NASDAQ:HCAT) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.03 by 33.33 percent. This is unchanged from the same period last year. The company reported quarterly sales of $70.487 million which beat the analyst consensus estimate of $69...
08-07 04:04
Health Catalyst to Announce Second Quarter 2026 Operating Results and Host Conference Call on Thursday, August 6, 2026
Health Catalyst, Inc. (Nasdaq: HCAT) will release its second quarter 2026 operating results on August 6, 2026, after market close, and host a conference call at 5:00 pm ET to review the results. U.S. participants can join by dialing 800-274-8461, while international participants can dial 203-518-9814, using conference ID “HCATQ226.” A live audio webcast will be available at https://ir.healthcatalyst.com/, with a replay accessible for 90 days post...
07-28 21:30
